Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
暂无分享,去创建一个
J. Qiao | A. Lusis | J. Huber | J. Berliner | N. Leitinger | B. Ivandic | M. Navab | S. Hama | K. Faull | A. Fogelman | A. Watson | F. D. de Beer | D. Grass | F. D. Beer
[1] J. Qiao,et al. Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[2] A. Kleinfeld,et al. Transport of long-chain native fatty acids across lipid bilayer membranes indicates that transbilayer flip-flop is rate limiting. , 1997, Biochemistry.
[3] A. Lusis,et al. Secretory non-pancreatic phospholipase A2: influence on lipoprotein metabolism. , 1997, Journal of lipid research.
[4] J. Huber,et al. Oxidized Lipids in Atherogenesis: Formation, Destruction and Action , 1997, Thrombosis and Haemostasis.
[5] Wei Sha,et al. Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo * , 1997, The Journal of Biological Chemistry.
[6] N. Ueda,et al. Arachidonate 12-lipoxygenases. , 1997, Progress in lipid research.
[7] B. Johansen,et al. Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[8] W. Stremmel,et al. Effect of surface and intracellular pH on hepatocellular fatty acid uptake. , 1996, The American journal of physiology.
[9] P. Shah,et al. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[10] R. Terkeltaub,et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. , 1996, The Journal of clinical investigation.
[11] J. Witztum,et al. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. , 1996, The Journal of clinical investigation.
[12] P. Edwards,et al. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[13] C. F. Bennett,et al. Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. , 1996, The Journal of clinical investigation.
[14] R. Gross,et al. Alterations in individual molecular species of human platelet phospholipids during thrombin stimulation: electrospray ionization mass spectrometry-facilitated identification of the boundary conditions for the magnitude and selectivity of thrombin-induced platelet phospholipid hydrolysis. , 1996, Biochemistry.
[15] H. Sugimoto,et al. Purification, cDNA Cloning, and Regulation of Lysophospholipase from Rat Liver (*) , 1996, The Journal of Biological Chemistry.
[16] J. Berliner,et al. The role of oxidized lipoproteins in atherogenesis. , 1996, Free radical biology & medicine.
[17] M. Kasper,et al. Secretory group II phospholipase A2 in human atherosclerotic plaques. , 1995, Atherosclerosis.
[18] J. Berliner,et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. , 1995, The Journal of clinical investigation.
[19] M. Kasper,et al. Immunohistochemical localisation of a secretory group-II phosholipase A2 in human atherosclerotic plaques , 1995 .
[20] P. Edwards,et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. , 1995, Circulation.
[21] L. Sarda,et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells , 1995, Cell.
[22] E. Miller,et al. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[23] Xianlin Han,et al. Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Witztum,et al. The oxidation hypothesis of atherosclerosis , 1994, The Lancet.
[25] J. Qiao,et al. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. , 1994, The Journal of clinical investigation.
[26] J. Browning,et al. Recombinant secreted nonpancreatic phospholipase A2 induces a synovitis-like inflammation in the rat air pouch. , 1994, The Journal of rheumatology.
[27] J. Qiao,et al. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. , 1993, Science.
[28] A. Sevanian,et al. Enhanced interfacial catalysis and hydrolytic specificity of phospholipase A2 toward peroxidized phosphatidylcholine vesicles. , 1993, Archives of biochemistry and biophysics.
[29] F. Parhami,et al. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. , 1993, The Journal of clinical investigation.
[30] B. Auerbach,et al. A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid. , 1992, Analytical biochemistry.
[31] A. J. Valente,et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. , 1991, The Journal of clinical investigation.
[32] D. Steinberg,et al. Role of oxidised low density lipoprotein in atherogenesis. , 1993, British heart journal.
[33] M. Territo,et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. , 1990, The Journal of clinical investigation.
[34] J L Witztum,et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.
[35] D. Steinberg,et al. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[36] L. Stevenson,et al. Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. , 1988, The Journal of clinical investigation.
[37] M. Territo,et al. Modification of the Recalde method for the isolation of human monocytes. , 1988, Journal of lipid research.
[38] A. Sevanian,et al. Lipid peroxidation and phospholipase A2 activity in liposomes composed of unsaturated phospholipids: a structural basis for enzyme activation. , 1988, Biochimica et biophysica acta.
[39] D. Steinberg,et al. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. , 1988, Journal of lipid research.
[40] M. Phillips,et al. Mechanism of the hepatic lipase induced accumulation of high-density lipoprotein cholesterol by cells in culture. , 1985, Biochemistry.
[41] A. Sevanian,et al. Phospholipase A2 dependent release of fatty acids from peroxidized membranes. , 1985, Journal of free radicals in biology & medicine.
[42] D. Epps,et al. Rapid separation of lipid classes in high yield and purity using bonded phase columns. , 1985, Journal of lipid research.
[43] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.
[44] R. Havel,et al. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.
[45] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.